
|Articles|February 4, 2021
USP Biologics 5-step Process Highlights
Author(s)USP
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
Pfizer Phase IIb Data Support Monthly GLP-1 Dosing for Obesity
3
FDA Clears Affinia’s AFTX-201 for Phase I/II BAG3 Cardiomyopathy Trial
4
SK bioscience Licensing Deal Targets Access Gaps in RSV Prevention
5